市场调查报告书
商品编码
1521231
2024-2032 年按产品(发电机、仪器、配件)、应用(普通外科、腹腔镜手术)、最终用户(医院和专科诊所、门诊手术中心)和地区分類的血管密封装置市场报告Vessel Sealing Devices Market Report by Product (Generators, Instruments, Accessories), Application (General Surgery, Laparoscopic Surgery), End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers), and Region 2024-2032 |
IMARC Group年,全球容器密封装置市场规模达到19亿美元。
血管封闭装置是指在非侵入性外科手术中使用的器械,以方便开腹和腹腔镜手术中的解剖和止血。电热双极容器密封器和超音波剪切机是一些常用的容器密封装置。它们由超音波、双极和混合能量组成,有助于凝固、切割和解剖应用。血管封闭装置广泛用于透过使管壁中的胶原蛋白和弹性蛋白变性并完全闭塞血管来封闭血管壁。这些设备易于使用,需要更少的操作时间,有助于减少失血,提供卓越的效率和可靠性,并且具有成本效益。因此,血管封闭装置广泛应用于专科诊所、医院和门诊手术中心。
更容易患慢性病的老年人口不断增加是创造积极市场前景的关键因素之一。血管封闭装置广泛用于治疗大肠直肠癌、颈部手术、腋窝淋巴结清除及慢性肝炎等。此外,腹腔镜手术中产品的广泛采用,因为它们是微创且术后疼痛较少,有利于市场成长。除此之外,监测热量和能量分布的超音波技术以及有助于更强和均匀压缩的双极设备的引入也为市场成长提供了推动力。此外,手术期间对安全有效的器械以降低感染率和失血量的需求不断增加,导致医疗密封设备的整体销售增加,从而对市场成长产生积极影响。其他因素,包括新型、高品质血管密封装置的开发、妇科、泌尿科、心血管和骨科手术数量的增加,以及医疗行业的显着扩张,预计将推动市场成长。
The global vessel sealing devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.
Vessel sealing devices refer to instruments used in non-invasive surgical procedures to facilitate dissection and hemostasis during open and laparoscopic procedures. Electrothermal bipolar vessel sealers and ultrasonic shears are some of the commonly used vessel sealing devices. They consist of ultrasonic, bipolar and hybrid energies and are helpful in coagulation, cutting and dissection applications. Vessel sealing devices are widely used to seal the vessel wall by denaturing the collagen and elastin in the wall and completely occluding the blood vessel. These devices are easy to use, require less operational time, assist in reducing blood loss, offer superior efficiency and reliability, and are cost-effective. As a result, vessel sealing devices are widely used in specialty clinics, hospitals and ambulatory surgical centers.
The increasing geriatric population that is more prone to chronic diseases is one of the key factors creating a positive outlook for the market. Vessel sealing devices are widely used to treat colorectal cancer, neck surgery, axillary dissection, and chronic hepatitis, amongst others. Additionally, the widespread product adoption in laparoscopic surgeries as they are minimally invasive and cause less postoperative pain, is favoring the market growth. Apart from this, the introduction of ultrasound technology that monitors the distribution of heat and energy and bipolar devices that assist in stronger and uniform compression, are also providing a thrust to the market growth. Moreover, the increasing demand for safe and effective instruments during surgeries to reduce infection rates and blood loss is inflating the overall sales of medical sealing devices, thus positively impacting the market growth. Other factors, including the development of novel, high-quality vessel sealing devices, a rise in the number of gynecological, urological, cardiovascular and orthopedic surgeries, and significant expansion in the medical industry, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global vessel sealing devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
Generators
Instruments
Accessories
General Surgery
Laparoscopic Surgery
Hospitals and Specialty Clinics
Ambulatory Surgical Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, BOWA-electronic GmbH & Co. KG, Erbe Elektromedizin GmbH, Hologic Inc., Intuitive Surgical Inc., Johnson & Johnson, KLS Martin Group, Lamidey Noury Medical, Medtronic plc, Olympus Corporation, OmniGuide Holdings Inc. and Xcellance Medical Technologies Private Limited.